Investor's Business Daily on MSN7d
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025.
Millennial Skin on MSN3mon
Botox vs. Jeuveau vs. Dysport: Which Wrinkle Fighter Wins?
Jeuveau’s formulation is very similar to Botox, but it’s specifically marketed for cosmetic use, which makes it a great ...
Seeking Alpha14d
Evolus: Still Bullish, But Business Faces Tricky Challenges In '25
It is keeping the price of Jeuveau close to that of Botox, operating a cash-pay only model — and the product itself had shown non-inferiority, or hinted at superiority, when evaluated against ...